Bedrosian Camille L

CIK 00013269694 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001326969

Recent Transactions

50 trades

Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$40.29/sh−12,500→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$64.68/sh−17,500→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$52.67/sh−10,350→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$49.13/sh−9,730→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$66.71/sh−17,500→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$64.77/sh−17,500→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-09-01$68.92/sh−25,000→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-09-01$85.00/sh−5,925→ 0 total
Disposition to Issuer
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-09-01$85.00/sh−16,300→ 5,925 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-08-18+22,807→ 288,092 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-06-18+9,730→ 9,730 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-06-18+5,925→ 22,225 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-03-05+95,990→ 265,285 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2026-03-05+143,985→ 143,985 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-03-02$14.58/sh−6,461→ 169,295 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-12-01$14.35/sh−6,580→ 175,756 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-09-30$14.58/sh−12,039→ 182,336 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-24+4,712→ 4,712 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2025-06-24+7,037→ 7,037 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2025-06-18+4,000→ 7,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-18−4,000→ 0 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-11+6,900→ 16,300 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2025-06-11+10,350→ 10,350 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-31$3.47/sh−12,425→ 194,375 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-06+68,420→ 206,800 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2025-03-06+102,630→ 102,630 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-12-02$5.54/sh−5,421→ 138,380 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-30$3.20/sh−11,442→ 143,801 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-06-21+3,000→ 3,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2024-06-21−3,000→ 0 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2024-06-18+4,000→ 4,000 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-06-18+14,000→ 14,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-06-07+12,500→ 12,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-07+3,400→ 9,400 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-04-16+96,910→ 155,243 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2024-04-16+120,000→ 120,000 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-11-27+58,333→ 58,333 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2023-11-27+162,500→ 162,500 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2023-06-21+14,000→ 14,000 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2023-06-21+3,000→ 3,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2023-06-16+17,500→ 17,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-06-16+6,000→ 6,000 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01$45.25/sh−3,881→ 46,720 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-03-01+2,663→ 50,601 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2022-06-17+17,500→ 17,500 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2022-06-08+20,000→ 20,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01$66.62/sh−2,821→ 33,938 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-03-01+14,000→ 47,938 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-01-30$66.30/sh−1,657→ 36,759 total

Companies

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov